The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $50.85

Today's change+1.42 +2.87%
Updated July 20 4:00 PM EDT. Delayed by at least 15 minutes.
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $50.85

Today's change+1.42 +2.87%
Updated July 20 4:00 PM EDT. Delayed by at least 15 minutes.

Abbott Laboratories Hits New 52-week High

Abbott Laboratories closed up sharply Thursday, rallying (U.S.)$1.42 or 2.87% to (U.S.)$50.85 and setting a new 52-week high. Over the last five days, shares have gained 5.76% and 32.39% year to date. Shares have outperformed the S&P 500 by 5.40% during the last year.

Key company metrics

  • Open(U.S.) $49.68
  • Previous close(U.S.) $49.43
  • High(U.S.) $51.13
  • Low(U.S.) $49.35
  • Bid / Ask(U.S.) $50.88 / (U.S.) $51.09
  • YTD % change+32.39%
  • Volume12,330,841
  • Average volume (10-day)5,353,826
  • Average volume (1-month)6,428,175
  • Average volume (3-month)6,453,445
  • 52-week range(U.S.) $37.38 to (U.S.) $51.13
  • Beta1.57
  • Trailing P/E56.45×
  • P/E 1 year forward20.01×
  • Forward PEG1.81×
  • Indicated annual dividend(U.S.) $1.06
  • Dividend yield2.08%
  • Trailing EPS(U.S.) $0.90
Updated July 20 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.13%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue6,3355,3335,3025,333
Total other revenue--------
Total revenue6,3355,3335,3025,333
Gross profit3,2913,0233,0173,052
Total cost of revenue3,0442,3102,2852,281
Total operating expense6,5374,3854,4054,517
Selling / general / administrative2,2991,6061,6181,746
Research & development541338352348
Depreciation / amortization522121140145
Interest expense (income), net operating--------
Unusual expense (income)1311010-3
Other operating expenses, total--------
Operating income-202948897816
Interest income (expense), net non-operating-226-153-117-103
Gain (loss) on sale of assets--------
Other--------
Income before tax736875-179715
Income after tax386765-357599
Income tax, total350110178116
Net income419798-329615
Total adjustments to net income--------
Net income before extra. items386765-357599
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items386765-357599
Inc. avail. to common incl. extra. items419798-329615
Diluted net income419798-329615
Dilution adjustment----00
Diluted weighted average shares1,7351,4841,4761,480
Diluted EPS excluding extraordinary itemsvalue per share0.220.52-0.240.40
Dividends per sharevalue per share0.270.260.260.26
Diluted normalized EPSvalue per share0.260.52-0.240.40